Sunday , 19 January 2025
Home Health Two Venture Investors Offer Their Takes on the State of Biotech Investing Today
Health

Two Venture Investors Offer Their Takes on the State of Biotech Investing Today

Two Venture Investors Offer Their Takes on the State of Biotech Investing Today

The way venture capital firms invest in biotech startups has changed. Veteran VCs Chris Garabedian and Arjun Goyal offered their perspectives during a panel discussion at the World Medical Innovation Forum.

The post Two Venture Investors Offer Their Takes on the State of Biotech Investing Today appeared first on MedCity News.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

AstraZeneca’s Calquence has expanded its FDA approval to include first-line treatment of...

This interactive chart allows users to track public opinion on the Affordable...

By MIKE MAGEE In case you’ve missed it, sleep is all the...

Teladoc Health has joined Amazon’s Health Benefits Connector. Other companies offered through...